General Information of Drug (ID: DMQLLVL)

Drug Name
ASP3662
Indication
Disease Entry ICD 11 Status REF
Alzheimer disease 8A20 Phase 1 [1]
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C19H16ClF3N4O2
Canonical SMILES
CC(C)(C1=NN=C(N1C)C2=C(C=C(C=C2)C(=O)N)F)OC3=C(C=C(C=C3F)Cl)F
InChI
1S/C19H16ClF3N4O2/c1-19(2,29-15-13(22)7-10(20)8-14(15)23)18-26-25-17(27(18)3)11-5-4-9(16(24)28)6-12(11)21/h4-8H,1-3H3,(H2,24,28)
InChIKey
CMQOKZCYVZFZLZ-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
44598960
TTD ID
D00UEC

References

1 Clinical pipeline report, company report or official report of Astellas Pharma.